Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Metabolic States of the Body: The Postabsorptive State01:18

Metabolic States of the Body: The Postabsorptive State

The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trauma care in Morocco: observations and opportunities from an American Association for the Surgery of Trauma (AAST) delegation visit.

Trauma surgery & acute care open·2026
Same author

Dissecting bone marrow and plasma exosomal microRNA profiles following trauma.

Surgery·2026
Same author

Evidence-based, cost-effective management of lower gastrointestinal bleeding. An algorithm of the journal of trauma and acute care surgery emergency general surgery algorithms work group.

The journal of trauma and acute care surgery·2026
Same author

Evidence-based, cost-effective management of upper gastrointestinal hemorrhage. An algorithm of the Journal of Trauma and Acute Care Surgery emergency general surgery algorithms work group.

The journal of trauma and acute care surgery·2026
Same author

Population Heterogeneity in Iron Biomarkers by Age, Sex, Menopausal Status, and Race in Healthy U.S. Adults: A Cross-Sectional Analysis from the All of Us Research Program.

Nutrients·2026
Same author

Duodenal injuries: what you need to know.

The journal of trauma and acute care surgery·2026

Related Experiment Video

Updated: Jun 10, 2026

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
09:35

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

Gender differences in glucose variability after severe trauma.

Alicia M Mohr1, Robert F Lavery, Ziad C Sifri

  • 1Department of Surgery, UMDNJ-New Jersey Medical School, Newark, New Jersey 07103, USA. mohr@umdnj.edu

The American Surgeon
|August 24, 2010
PubMed
Summary
This summary is machine-generated.

Blood glucose (BG) variability after trauma impacts outcomes differently in men and women. In males, higher BG variability correlates with increased mortality, but this association was not observed in females, suggesting gender-specific post-injury glucose management needs.

More Related Videos

Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing
10:32

Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing

Published on: January 11, 2013

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
06:59

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

Published on: November 13, 2016

Related Experiment Videos

Last Updated: Jun 10, 2026

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
09:35

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing
10:32

Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing

Published on: January 11, 2013

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
06:59

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

Published on: November 13, 2016

Area of Science:

  • Trauma critical care
  • Endocrinology
  • Gender-specific physiology

Background:

  • Physiological responses to trauma, including glucose metabolism, can vary by gender.
  • Hyperglycemia and blood glucose (BG) variability are known predictors of poor outcomes following trauma.
  • Understanding gender-specific differences in BG regulation post-trauma is crucial for optimizing patient management.

Purpose of the Study:

  • To investigate whether blood glucose (BG) levels and BG variability after trauma are gender-specific.
  • To determine the correlation between BG levels, BG variability, and mortality/morbidity in trauma patients.
  • To explore potential gender-based differences in the predictive value of BG metrics for patient outcomes.

Main Methods:

  • Retrospective observational cohort study of 1915 trauma patients admitted to intensive care.
  • Analysis of admission BG and all BG values during the first week of ICU stay.
  • Calculation of mean BG and BG variability for each patient, stratified by gender.

Main Results:

  • Overall mortality rate was 12%; 76% of deaths occurred in patients with admission BG > 125 mg/dL.
  • Increased BG variability was significantly associated with higher mortality in male patients.
  • Female BG variability did not show a significant correlation with mortality, unlike in males.

Conclusions:

  • Failed glucose homeostasis, indicated by BG variability, is a marker of endocrine dysfunction post-trauma.
  • Elevated BG variability in males after trauma is linked to increased mortality risk.
  • BG levels and variability do not reliably predict mortality in female trauma patients, highlighting gender-specific differences in post-injury glucose management.